-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Verastem, Maintains $18 Price Target

Benzinga·09/11/2026 10:29:05
Listen to the news
BTIG analyst Jeet Mukherjee reiterates Verastem (NASDAQ:VSTM) with a Buy and maintains $18 price target.